Gaitherburg-based OpGen Inc. has entered a new partnership with pharmaceutical giant Merck & Co. in a collaboration officials say will help more quickly combat so-called superbugs with rapid diagnostic tests.
OpGen, which has focused on creating rapid DNA diagnostic tools to improve antibiotic decision-making, has been building a bank of bacterial pathogens to offer more accurate infection diagnostic testing.
{iframe}http://www.bizjournals.com/washington/news/2016/11/14/opgen-teams-with-merck-to-fight-superbugs.html?ana=e_me_set1&s=newsletter&ed=2016-11-15&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1479396194&j=76466641{/iframe}